{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:50Z","timestamp":1794561950233,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006687","name":"University Claude Bernard Lyon 1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","award":["EA7426"],"award-info":[{"award-number":["EA7426"]}],"id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2025.100007","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:35:35Z","timestamp":1768570535000},"page":"100007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes"],"prefix":"10.1016","volume":"16","author":[{"given":"Camille","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Perrine","family":"Foray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Micoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Gossez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.aicoj.2025.100007_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"10219","key":"10.1016\/j.aicoj.2025.100007_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100007_bib0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing sepsis as a global health priority - A WHO resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100007_bib0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100007_bib0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat Immunol."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100007_bib0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","article-title":"Redefining critical illness","volume":"28","author":"Maslove","year":"2022","journal-title":"Nat Med."},{"key":"10.1016\/j.aicoj.2025.100007_bib0040","article-title":"Sepsis-induced immunosuppression","author":"Torres","year":"2021","journal-title":"Annu Rev Physiol."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100007_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/cc10112","article-title":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients","volume":"15","author":"Guignant","year":"2011","journal-title":"Crit Care."},{"issue":"15","key":"10.1016\/j.aicoj.2025.100007_bib0050","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1073\/pnas.0809422106","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis","volume":"106","author":"Huang","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100007_bib0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molmed.2014.01.002","article-title":"The new normal: immunomodulatory agents against sepsis immune suppression","volume":"20","author":"Hutchins","year":"2014","journal-title":"Trends Mol Med."},{"issue":"9","key":"10.1016\/j.aicoj.2025.100007_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092260","article-title":"The end of \"One Size Fits All\" sepsis therapies: toward an individualized approach","volume":"10","author":"Vincent","year":"2022","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100007_bib0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","article-title":"Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine","volume":"12","author":"Cajander","year":"2024","journal-title":"Lancet Respir Med."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0075","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1744980","article-title":"ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance","volume":"9","author":"Orme","year":"2020","journal-title":"Oncoimmunology."},{"issue":"7","key":"10.1016\/j.aicoj.2025.100007_bib0080","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-10-0250","article-title":"Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma","volume":"17","author":"Frigola","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"10","key":"10.1016\/j.aicoj.2025.100007_bib0085","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00262-021-02898-4","article-title":"The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte","volume":"70","author":"Han","year":"2021","journal-title":"Cancer Immunol Immunother."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100007_bib0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SHK.0000000000000981","article-title":"Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis","volume":"49","author":"Stortz","year":"2018","journal-title":"Shock."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100007_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/SHK.0000000000002156","article-title":"Predictive value of soluble programmed cell Death Ligand-1 in the progression of septic patients to chronic critical illness in the intensive care unit: a prospective observational clinical study","volume":"60","author":"Zeng","year":"2023","journal-title":"Shock."},{"issue":"10","key":"10.1016\/j.aicoj.2025.100007_bib0100","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00134-025-08110-w","article-title":"Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases","volume":"51","author":"Monneret","year":"2025","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.b.21043","article-title":"Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples","volume":"84","author":"Demaret","year":"2013","journal-title":"Cytometry B Clin Cytom."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100007_bib0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.aicoj.2025.100007_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.795052","article-title":"Monocyte trajectories endotypes are associated with worsening in septic patients","volume":"12","author":"Bodinier","year":"2021","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100007_bib0120","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1515\/cclm-2023-0232","article-title":"Serum sPD-L1 levels are elevated in patients with viral diseases, bacterial sepsis or in patients with impaired renal function compared to healthy blood donors","volume":"61","author":"Loacker","year":"2023","journal-title":"Clin Chem Lab Med."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13049","article-title":"Serum-soluble PD-L1 may be a potential diagnostic biomarker in sepsis","volume":"94","author":"Sun","year":"2021","journal-title":"Scand J Immunol."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100007_bib0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12026-022-09302-y","article-title":"Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome","volume":"70","author":"Derigs","year":"2022","journal-title":"Immunol Res."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/sji.12509","article-title":"Serum sPD-L1, upregulated in sepsis, may reflect disease severity and clinical outcomes in septic patients","volume":"85","author":"Liu","year":"2017","journal-title":"Scand J Immunol."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100007_bib0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SHK.0000000000001171","article-title":"Predictive value of soluble programmed death-1 for severe sepsis and septic shock during the first week in an intensive care unit","volume":"51","author":"Zhao","year":"2019","journal-title":"Shock."},{"issue":"8","key":"10.1016\/j.aicoj.2025.100007_bib0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8686","article-title":"Long-term host immune response trajectories among hospitalized patients with sepsis","volume":"2","author":"Yende","year":"2019","journal-title":"JAMA Netw Open."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100007_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/SHK.0000000000001228","article-title":"Integrin and PD-1 ligand expression on circulating extracellular vesicles in systemic inflammatory response syndrome and sepsis","volume":"52","author":"Kawamoto","year":"2019","journal-title":"Shock."},{"key":"10.1016\/j.aicoj.2025.100007_bib0155","first-page":"8","article-title":"Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist","author":"Ng","year":"2019","journal-title":"Elife."}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025020217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025020217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:35:25Z","timestamp":1794558925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025020217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"alternative-id":["S2110582025020217"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100007","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100007"}}